Crowdfunding triggers Capital Increase of 800,000 Euros at Rodos Biotarget

Hannover, 17 August 2017. Rodos Biotarget is the first German life-science company to initiate crowdfunding campaigns via two crowd platforms. In 2016, a first round took place with Seedmatch, and a current financing round is running with

Hannover, 17 August 2017. Rodos Biotarget is the first German life-science company to initiate crowdfunding campaigns via two crowd platforms. In 2016, a first round took place with Seedmatch, and a current financing round is running with aescuvest. With this approach, in addition to raising capital for further corporate development, Rodos Biotarget has two further objectives:

. With this approach, in addition to raising capital for further corporate development, Rodos Biotarget has two further objectives…

Download the Press Release PDF.

Posted in Press